Cancer Research Horizons: Funding, Team & Investors | Startup Intros

Loading organizations...

Cancer Research Horizons: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 4, 2025	Laigo Bio	$13.4M Seed	Mariette van der Velden, Thierry Laugel	Lola Buono, Neill Moray Mackenzie, Phil Masterson, Eurazeo, Emil Pot, ROM Utrecht Region
Oct 6, 2025	Trogenix	$94.1M Series A	Max Bautin	Calculus Capital, Iain Foulkes, Eli Lilly and Company, LongeVC, Meltwind, National Brain Tumor Society
Sep 30, 2025	AiM Medical Robotics	$8.1M AiM Medical Robotics Series A	1540 Ventures, IQ Capital, Alex Wilson	Angel Star Ventures, Harvard Business School Angels, Keiretsu Forum, New York Angels, Sontag Foundation, SWAN Impact Network, Worcester Polytechnic Institute
May 1, 2024	Infinitopes	$16.0M Seed	Hugo Villanueva, Ph.D.	Phil Masterson, Cancer Research Institute, CRIS Cancer Foundation, John W Cassidy, Julia Schrameier, Martlet Capital, Meltwind, Saras Capital, Wilbe Capital
May 1, 2022	BioCaptiva	$3.0M Seed	—	Archangel Investors, Andrea Young, Kerry Sharp
Nov 1, 2016	Achilles Therapeutics	$16.1M Other Equity	Cancer Research Horizons, Syncona, UCL	Francis Crick Institute, UCL Business
	Laigo Bio	$6.0M Laigo Bio Seed Extension Mar 2026	Kurma Partners, Biovance Capital, Joao Incio, MD PhD	Angelini Ventures, ArgoBio, Curie Capital, Eurazeo, Oncode Oncology Bridge Fund, ROM Utrecht Region